We are live on ! Find out more
ARMC

American Research & Management Company Portfolio holdings

AUM $362M
1-Year Est. Return 8.06%
This Fund
S&P 500
This Quarter Est. Return
-1.12%
1 Year Est. Return
-8.06%
3 Year Est. Return
+35.06%
5 Year Est. Return
+60.88%
10 Year Est. Return
AUM
$454M
AUM Growth
-$8.55M
Cap. Flow
+$5.97M
Cap. Flow %
1.32%
Top 10 Hldgs %
31.03%
Holding
429
New
29
Increased
50
Reduced
86
Closed
8
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PIO icon
351
Invesco Global Water ETF
PIO
$274M
$3K ﹤0.01%
70
VOE icon
352
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24.3B
$3K ﹤0.01%
17
VTRS icon
353
Viatris
VTRS
$18.8B
$3K ﹤0.01%
297
-170
-36% -$2.24K
VTV icon
354
Vanguard Morningstar Value ETF
VTV
$192B
$3K ﹤0.01%
20
XAIR icon
355
Beyond Air
XAIR
$4.41M
$3K ﹤0.01%
1
ERF
356
DELISTED
Enerplus Corporation
ERF
$3K ﹤0.01%
200
CFMS
357
DELISTED
Conformis, Inc. Common Stock
CFMS
$3K ﹤0.01%
200
ACAD icon
358
Acadia Pharmaceuticals
ACAD
$5.02B
$2K ﹤0.01%
100
BKCH icon
359
Global X Blockchain ETF
BKCH
$261M
$2K ﹤0.01%
25
C icon
360
Citigroup
C
$223B
$2K ﹤0.01%
40
CI icon
361
Cigna
CI
$73.7B
$2K ﹤0.01%
8
GNOM icon
362
Global X Genomics & Biotechnology ETF
GNOM
$92.3M
$2K ﹤0.01%
+38
New +$2.4K
IWM icon
363
iShares Russell 2000 ETF
IWM
$80.8B
$2K ﹤0.01%
11
-9
-45% -$1.84K
KOMP icon
364
State Street SPDR S&P Kensho New Economies Composite ETF
KOMP
$2.67B
$2K ﹤0.01%
+37
New +$1.92K
LUMN icon
365
Lumen
LUMN
$6.23B
$2K ﹤0.01%
142
ZNGA
366
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$2K ﹤0.01%
170
AVDL
367
DELISTED
Avadel Pharmaceuticals
AVDL
$1K ﹤0.01%
100
SRTA
368
Strata Critical Medical Inc
SRTA
$528M
$1K ﹤0.01%
125
EA
369
DELISTED
Electronic Arts
EA
$1K ﹤0.01%
5
GH icon
370
Guardant Health
GH
$21.7B
$1K ﹤0.01%
20
HUT
371
Hut 8
HUT
$9.79B
$1K ﹤0.01%
20
IDXX icon
372
Idexx Laboratories
IDXX
$43.7B
$1K ﹤0.01%
1
DFTX
373
Definium Therapeutics
DFTX
$5.51B
$1K ﹤0.01%
67
MSTR icon
374
Strategy Inc
MSTR
$50.6B
$1K ﹤0.01%
20
OXY.WS icon
375
Occidental Petroleum Corp Warrants
OXY.WS
$34.9B
$1K ﹤0.01%
27

Similar funds

American Research & Management Company's Q1 2022 Portfolio in Review

As of Q1 2022, American Research & Management Company held 429 positions worth $454M, down 1.9% from $462M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

American Research & Management Company's Q1 2022 filing shows 29 new, 50 increased, 86 reduced and 8 closed positions. Its largest new stake was Old National Bancorp Series A Preferred Stock: 36,772 shares worth $980K. The largest sale was U.S. Bancorp Depositary Shares, each representing 1/1000th interest in a share of Series F Non-Cumul, an estimated $1.57M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Miscellaneous and Healthcare.

  • American Research & Management Company's largest Q1 2022 buy was Old National Bancorp Series A Preferred Stock: 36,772 shares worth $980K.
  • American Research & Management Company added most to Okta in Q1 2022, an estimated $1.08M increase.
  • American Research & Management Company's biggest Q1 2022 reduction was iShares Gold Trust, cutting an estimated $1.03M.
  • American Research & Management Company fully exited U.S. Bancorp Depositary Shares, each representing 1/1000th interest in a share of Series F Non-Cumul in Q1 2022, selling an estimated $1.57M.
  • American Research & Management Company's ten largest holdings make up 31% of its $454M portfolio in Q1 2022.
  • American Research & Management Company opened 29 new positions and closed 8 in Q1 2022.
  • American Research & Management Company's portfolio value fell 1.9% quarter-over-quarter to $454M.

Based on American Research & Management Company's 13F filing for Q1 2022, filed 21 Apr 2022.